LIFECORE BIOMEDICAL, INC. \DE\
LFCR · Pharmaceutical Preparations · 37.5M shares · +6%/yr ↑ dilution · EDGAR filings ↗
Net buyback after stock comp: -$1M (gross $5M, SBC $6M)
Reference price $7.12 · est. market cap ~$267M — last insider sale, 2025-05-28 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D50Injectables CDMO with a net loss and negative equity, but small positive FCF.
Strengths
- Positive free cash flow — FCF $4M, current ratio 3.5 (46th)
Risks
- Net loss — ROA -8%
- Negative equity — D/E -10.0
- Customer-concentration/transition (CDMO) risk — per 10-K
Notable findings
- Restatement6 million primarily related to legal expenses related to legacy matters including the SEC subpoena, an activist investor and a securities class action claim, as well as costs associated with the legac 8-K ↗
- Negative equityNegative book equity (debt/equity -10.02)
- Exec changeRecent 8-K item 5.02 8-K ↗
- Material weaknessThese risks include, but are not limited to, the following: 6 Table of Contents Risks related to our internal controls and financial reporting • We have identified material weaknesses in our
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Notable holderHeld by 4 notable fund(s): STATE STREET CORP, GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC +1 more (as of 2026-03-31)
- Revenue declineRevenue -22.9% YoY
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Revenue growth (QoQ)
-22.9%
Debt / equity
-10.0×
Current ratio
3.5×
Tangible book value
-$28M
Cash & investments
$17M
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-04 | Kiper Christopher S | Grant | 26K | — |
| 2026-06-04 | Johnson Paul Harold | Grant | 26K | — |
| 2026-06-04 | Antunes Humberto Calheiros | Grant | 26K | — |
| 2026-06-04 | Korenberg Matthew E | Grant | 26K | — |
| 2026-06-04 | Aryeh Jason | Grant | 26K | — |
| 2026-06-04 | Schechter Joshua | Grant | 26K | — |
| 2026-06-04 | HOUDE LOVAS KATRINA | Grant | 26K | — |
| 2026-06-04 | OBUS NELSON | Grant | 26K | — |
| 2026-05-20 | Josephs Paul | Tax withheld | 40K | $4.57 |
| 2026-04-14 | Salus Thomas D. | Tax withheld | 25K | $5.20 |
| 2026-03-02 | Salus Thomas D. | Grant | 30K | — |
| 2025-09-03 | Lake Ryan David | Tax withheld | 23K | $7.71 |
| 2025-07-15 | OBUS NELSON | Grant | 20K | — |
| 2025-07-15 | Johnson Paul Harold | Grant | 20K | — |
| 2025-07-15 | Aryeh Jason | Grant | 20K | — |
| 2025-07-15 | Korenberg Matthew E | Grant | 20K | — |
| 2025-07-15 | Antunes Humberto Calheiros | Grant | 20K | — |
| 2025-07-15 | Schechter Joshua | Grant | 20K | — |
| 2025-07-15 | HOUDE LOVAS KATRINA | Grant | 20K | — |
| 2025-07-15 | Kiper Christopher S | Grant | 20K | — |
| 2025-07-08 | Salus Thomas D. | Option exercise | 37K | — |
| 2025-07-08 | Salus Thomas D. | Tax withheld | 11K | $8.19 |
| 2025-07-08 | Lake Ryan David | Option exercise | 75K | — |
| 2025-07-08 | Lake Ryan David | Tax withheld | 33K | $8.19 |
| 2025-07-08 | Josephs Paul | Option exercise | 150K | — |
| 2025-07-08 | Josephs Paul | Tax withheld | 55K | $8.19 |
| 2025-05-28 | English Aron R. | Sell | 150K | $7.12 |
| 2025-05-27 | English Aron R. | Sell | 1.1M | $6.50 |
| 2025-05-23 | English Aron R. | Sell | 96K | $6.75 |
| 2025-05-20 | Josephs Paul | Tax withheld | 22K | $6.63 |
| 2025-05-13 | English Aron R. | Sell | 12K | $7.00 |
| 2025-05-12 | English Aron R. | Sell | 46K | $7.03 |
| 2025-05-09 | English Aron R. | Sell | 700 | $7.00 |
| 2025-05-08 | English Aron R. | Sell | 5.1K | $7.00 |
| 2025-05-07 | English Aron R. | Sell | 16K | $7.01 |
| 2025-05-06 | English Aron R. | Sell | 701 | $7.05 |
| 2025-05-05 | English Aron R. | Sell | 25K | $7.08 |
| 2025-04-14 | Salus Thomas D. | Grant | 45K | — |
| 2025-04-14 | Salus Thomas D. | Grant | 170K | — |
| 2025-01-08 | Josephs Paul | Buy | 17K | $5.74 |
All non-derivative Form 4 activity (SEC), newest first.
Supply chain
Customers (1)
Suppliers (0)
Named in the 10-K; linked when we track them.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-05 | Exec/director changeShareholder voteExhibits | filing ↗ |
| 2026-05-06 | ResultsReg FDExhibits | filing ↗ |
| 2026-03-16 | ResultsReg FDExhibits | filing ↗ |
| 2026-03-05 | 5.08 | filing ↗ |
| 2026-01-16 | Exec/director changeExhibits | filing ↗ |
| 2025-11-17 | Reg FDExhibits | filing ↗ |
| 2025-11-06 | ResultsReg FDExhibits | filing ↗ |
| 2025-10-31 | Shareholder vote | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-05 | 2026-06-04 | 0001005286-26-000023 ↗ |
| 8-K | 2026-05-06 | 2026-05-06 | 0001005286-26-000018 ↗ |
| 10-Q | 2026-05-06 | 2026-03-31 | 0001005286-26-000020 ↗ |
| 8-K | 2026-03-16 | 2026-03-16 | 0001005286-26-000007 ↗ |
| 8-K | 2026-03-05 | 2026-03-05 | 0001005286-26-000002 ↗ |
| 8-K | 2026-01-16 | 2026-01-14 | 0001628280-26-002400 ↗ |
| 8-K | 2025-11-17 | 2025-11-17 | 0001005286-25-000150 ↗ |
| 10-Q | 2025-11-06 | 2025-09-30 | 0001005286-25-000148 ↗ |
| 8-K | 2025-11-06 | 2025-11-06 | 0001005286-25-000146 ↗ |
| 8-K | 2025-10-31 | 2025-10-29 | 0001005286-25-000138 ↗ |
| 8-K | 2025-09-26 | 2025-09-22 | 0001005286-25-000133 ↗ |
| 8-K | 2025-08-18 | 2025-08-12 | 0001005286-25-000118 ↗ |